ISPOR - PCN175 Reimbursement of Anticancer Drugs in Canada- What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?

Full Text

PCN175 Reimbursement of Anticancer Drugs in Canada- What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?

Abstract

Authors

D. Cooper J.E. Tarride R. Goeree

Back to Volume 14, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now